Skip to Content

AP National Business

Merck has strong fourth quarter as COVID-19 treatment debuts

By TOM MURPHY AP Health Writer The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations, and the drugmaker’s COVID-19 treatment debuted with nearly $1 billion in sales. A 50% jump in sales for the Gardasil vaccine, which protects against cancer-causing human papilloma virus infections, also helped, Merck said Thursday. Overall, Merck earned $3.76 billion

Continue Reading

Company faces criminal charges over pipeline explosion

By MICHAEL RUBINKAM Associated Press An energy company already charged with violating Pennsylvania environmental laws during construction of the multibillion-dollar Mariner East pipeline system is facing more legal trouble. Prosecutors on Wednesday filed a new criminal case alleging the company’s negligence led to the 2018 explosion of a different pipeline near Pittsburgh. The state attorney

Continue Reading

France to start using Pfizer’s COVID-19 drug, first in EU

PARIS (AP) — France says it will start administering Pfizer’s coronavirus antiviral drug this week, the first pill for treating COVID-19 approved in the 27-nation EU. France is still reporting among the world’s highest per-capita daily infections, but virus-related critical care hospitalizations are easing. The French government on Wednesday started lifting restrictions related to the

Continue Reading

EU wants to allow natural gas, nuclear in green investment

By SAMUEL PETREQUIN Associated Press BRUSSELS (AP) — The European Commission wants to include nuclear energy and natural gas in its plans for building a climate-friendly future. Wednesday’s proposal from the European Commission has divided member countries and drawn outcry from environmentalists as “greenwashing.” The green labeling system would define what qualifies as an investment

Continue Reading